<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Evaluate 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=38726></link><description><![CDATA[Evaluate 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 12:56:03 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2021/09/12_3554238800_20210929171250_4206571768.gif]]></url></image><language>ko-KR</language><item><title><![CDATA[MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making]]></title><link>https://www.newswire.co.kr/newsRead.php?no=931292</link><description><![CDATA[YARDLEY, Pa.--(Business Wire/Korea Newswire)--Managed Markets Insight &amp; Technology (MMIT) and Evaluate, (a Welsh, Carson, Anderson &amp; Stowe and Hg portfolio company)—which joined forces last month to become a $1.6 billion global pharma commercial intelligence provider—announced the acquisition of Panalgo, a premier healthcare data analytics company that serves many of the largest bio...]]></description><pubDate>Wed, 29 Sep 2021 17:40:00 +0900</pubDate></item><item><title><![CDATA[MMIT/이밸류에이트, 파날고 인수로 제약 애널리틱스와 의사 결정에 속도와 신뢰 더해]]></title><link>https://www.newswire.co.kr/newsRead.php?no=931293</link><description><![CDATA[야들리, 펜실베니아--(Business Wire/뉴스와이어)--지난달 16억달러 규모의 글로벌 제약 인텔리전스 공급업체의 탄생을 알린 매니지드마켓인사이트앤테크놀로지(Managed Markets Insight &amp; Technology, 이하 ‘MMIT’)와 이밸류에이트(Evaluate)가 세계적 바이오제약·의료기기·위탁연구 조직에게 서비스를 제공하는 프리미엄 의료 데이터 분석 기업 ‘파날고(Panalgo)’를 인수한다고 발표했다.   이밸류에이트는 웰시카슨앤...]]></description><pubDate>Wed, 29 Sep 2021 17:40:00 +0900</pubDate></item></channel></rss>